ADUHELM

Peak

aducanumab-avwa

BLAINJECTIONINJECTABLEPriority Review
Approved
Jun 2021
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1

Clinical Trials (1)

NCT05097131N/ATerminated

An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

Started Nov 2021
29 enrolled
Alzheimers Disease